Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
Davis
Stephen M
SM
Department of Neurology, Royal Melbourne Hospital, and University of Melbourne, Parkville, Australia. stephen.davis@mh.org.au
Donnan
Geoffrey A
GA
D002986:Clinical Trials as Topic; D038524:Diffusion Magnetic Resonance Imaging; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018810:Magnetic Resonance Angiography; D018579:Patient Selection; D011994:Recombinant Proteins / Q000627:therapeutic use; D020521:Stroke / Q000175:diagnosis* / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator